Skip to main content

Nesina Dosage

Generic name: ALOGLIPTIN BENZOATE 6.25mg
Dosage form: tablet, film coated
Drug class: Dipeptidyl peptidase 4 inhibitors

Medically reviewed by Drugs.com. Last updated on Aug 7, 2023.

Recommended Dosage

  • The recommended dosage of NESINA is 25 mg taken orally once daily. Do not split tablets.
  • NESINA may be taken with or without food [see Clinical Pharmacology (12.3)].
  • Instruct patients if a dose is missed, not to double their next dose.

Patients with Renal Impairment

  • Assess renal function prior to initiation of NESINA and periodically thereafter [see Use in Specific Populations (8.6)].
  • No dose adjustment of NESINA is necessary for patients with mild renal impairment (creatinine clearance [CrCl] ≥60 mL/min).
  • The dose of NESINA is 12.5 mg once daily for patients with moderate renal impairment (CrCl ≥30 to <60 mL/min).
  • The dose of NESINA is 6.25 mg once daily for patients with severe renal impairment (CrCl ≥15 to <30 mL/min) or with end-stage renal disease (ESRD) (CrCl <15 mL/min or requiring hemodialysis). NESINA may be administered without regard to the timing of dialysis. NESINA has not been studied in patients undergoing peritoneal dialysis [see Use in Specific Populations (8.6), Clinical Pharmacology (12.3)].

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.